Top compounds associated with response to CDC5L


Feature Type Standardized
Nominal ANOVA
mRNA BX-912 GDSC1000 pan-cancer AAC 0.095 0.002
mRNA T0901317 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.16 0.002
mRNA DBeQ CTRPv2 pan-cancer AAC 0.11 0.002
mRNA B02 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.097 0.002
mRNA GSK-650394 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
Download CSV